Palliative Care Market Summary
According to Market Research Future analysis, the Palliative Care Market Size was estimated at 5.47 USD Billion in 2024. The palliative care industry is projected to grow from 5.875 USD Billion in 2025 to 12.0 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 7.4% during the forecast period 2025 - 2035. North America led the market with over 45.70% share, generating around USD 2.5 billion in revenue.
Palliative care market growth is driven by rising prevalence of chronic diseases, aging populations, increasing demand for home-based care services. Integration into mainstream healthcare systems supportive government policies enhance accessibility, improving quality of life for patients with serious illnesses care
WHO estimates approximately 56.8 million people globally require palliative care annually, with nearly 78% living in low- and middle-income countries. IHME Global Burden of Disease studies indicate about 61 million experience serious health-related suffering each year, while only a small proportion receive adequate services.
Key Market Trends & Highlights
The Palliative Care Market is experiencing significant growth driven by evolving healthcare practices and demographic shifts.
- Integration of palliative care into standard healthcare systems improves outcomes, supported by WHO resolution WHA67.19 globally implementation expanding.
- Telehealth expansion enables remote palliative care delivery, improving access and continuity of care for patients worldwide significantly services.
- North America leads market with 45.70% global revenue share driven by strong healthcare infrastructure and reimbursement systems.
- Europe holds second-largest market, valued at USD 1.64 billion in 2024 with 30% share globally region.
Market Size & Forecast
| 2024 Market Size | 5.47 (USD Billion) |
| 2035 Market Size | 12.0 (USD Billion) |
| CAGR (2025 - 2035) | 7.4% |
Major Players
Companies such as Bristol-Myers Squibb (US), Roche (CH), Novartis (CH), AstraZeneca (GB), Pfizer (US), Merck & Co. (US), Teva Pharmaceutical Industries (IL), Amgen (US), Eli Lilly and Company (US) are some of the major participants in the global market.